Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Much Is the Global Chickenpox Vaccine Market Valued at Present and by 2029?

The market size of the chickenpox vaccine has seen robust growth in the past few years. It projects a leap from $3.57 billion in 2024 to $3.76 billion in 2025 with a compound annual growth rate (CAGR) of 5.5%. Factors such as vaccine development, regulatory permissions, disease occurrence, immunization strategies, and public health campaigns have contributed significantly to the growth observed during the historic period.

In the impending years, it’s anticipated that the chickenpox vaccine market size will experience robust growth. With ” $4.82 billion in 2029 at a compound annual growth rate (CAGR) of 6.4% being the projected growth, it can be attributed to factors such as public trust and perception, preparedness for pandemics, research and development, demand in emerging markets, and the growth of healthcare infrastructure. Key trends predicted for this period comprise of education campaigns for vaccines, monitoring of adverse events, strategic vaccine pricing, breakthrough innovation, and the application of artificial intelligence.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8581&type=smp

#What Drivers Are Influencing Growth In The Chickenpox Vaccine Market?

The increase in chickenpox cases is fueling the expansion of the chickenpox vaccine market. Chickenpox is a high-risk infectious disease caused by the varicella-zoster virus (VZV) and characterized by an itchy, fluid-filled rash. The multiplication of chickenpox occurrences implies the need for heightened varicella vaccine immunizations, hence, ramping up the necessity for chickenpox vaccines. A report in October 2023 by the National Library of Medicine (NLM), a biomedical library based in the US, found in a study on GP consultations regarding chickenpox from September 2016 to December 2022 that the average weekly rate was 3.4 per 100,000 people in England, peaking between weeks 13 and 15 each year. However, during the COVID-19 pandemic, the usual epidemic peaks did not occur, possibly due to social distancing measures and lockdowns. Nevertheless, in 2022, consultation rates among infants under one year old were higher than before the pandemic, indicating changes in disease transmission patterns. Consequently, the escalating frequency of chickenpox disease drives the upward trend in the chickenpox vaccine market.

The chickenpox vaccine market covered in this report is segmented –

1) By Vaccine: Monovalent Varicella Vaccine, Combination Varicella Vaccine

2) By Application: Mumps, Measles, Rubella, And Varicella Immunization, Herpes Zoster Immunization, Chickenpox Vaccination

3) By End-Users: Hospitals, Clinics, Other End-Users

Subsegments:

1) By Monovalent Varicella Vaccine: Live Attenuated Varicella Vaccine

2) By Combination Varicella Vaccine: Measles, Mumps, Rubella, And Varicella (MMRV) Vaccine

What Trends Are Currently Influencing Growth In The Chickenpox Vaccine Market?

Innovative pharmaceutical introductions are becoming a prominent trend in the chickenpox vaccine industry. The leading firms in this domain are focusing on creating cutting-edge drugs with higher effectiveness, unique derivatives and more to maintain their market position. For example, in November 2022, the World Health Organization (WHO) approved Sinovac Biotech Ltd.’s live, attenuated chickenpox (varicella) vaccine, credited as the first of its kind to receive this qualification. This vaccine, known as the Oka strain, is manufactured in the specialized Human Diploid Cell (SV-1 strain) produced by SINOVAC. The cells are cultivated and collected, then mixed with stabilizers and freeze-dried. Phase III efficacy trials showed that this vaccine boasted a seroconversion rate of 97.1% in children between the ages 1 to 12. The vaccine’s efficiency against varicella and breakthrough varicella was evaluated at 87.1% and 89.2% respectively, while providing 100% protection against mild to severe conditions.

Which Companies Play A Key Role In The Development Of The Chickenpox Vaccine Market?

Major companies operating in the chickenpox vaccine market include Merck & Co., Sanofi Pasteur, Takeda Pharmaceutical Company Limited, CSL Limited, Pfizer Inc., Seqirus, Serum Institute of India Pvt. Ltd., Bharat Biotech, Emergent BioSolutions Inc., Hualan Biological Engineering Inc., Shenzhen Kangtai Biological Products Co., Ltd., Chongqing Zhifei Biological Products Co., Ltd., Beijing Minhai Biotechnology Co., Ltd., Adimmune Corporation, Biological E. Limited, Walvax Biotechnology Co., Ltd., Zydus Cadila, Indian Immunologicals Ltd., Panacea Biotec Ltd., Bio Farma, PT Kalbe Farma Tbk, CanSino Biologics

https://www.thebusinessresearchcompany.com/report/chickenpox-vaccine-global-market-report

What Are The Key Regional Developments Shaping The Chickenpox Vaccine Market?

North America was the largest region in the chickenpox vaccine market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chickenpox vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=8581&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model